Haemonetics (HAE) Other financing activities (2009 - 2026)

Haemonetics' Other financing activities history runs 18 years deep, the most recent figure standing at -$13000.0 for Q1 2026.

• On a quarterly basis, Other financing activities rose 99.34% year-over-year to -$13000.0 in Q1 2026; TTM through Mar 2026 was -$102000.0, a 59.04% increase from a year earlier, with the FY2026 full-year figure at -$102000.0, up 59.04% from the prior year.
• Other financing activities advanced to -$13000.0 in Q1 2026 per HAE's latest filing, from -$614000.0 in the prior quarter.
• Across five years, Other financing activities topped out at $2.2 million in Q4 2022 and bottomed at -$2.4 million in Q4 2022.
• The 5-year median for Other financing activities is $25500.0 (2023), against an average of -$160611.1.
• Across the five-year window, Other financing activities jumped 211.36% in 2024 and plunged 1720.37% in 2025, its largest moves.
• Year by year, Other financing activities stood at -$2.4 million in 2022, then gained by 9.27% to -$2.1 million in 2023, then soared by 123.68% to $505000.0 in 2024, then plunged by 221.58% to -$614000.0 in 2025, then surged by 97.88% to -$13000.0 in 2026.
• Per Business Quant, the three latest HAE Other financing activities figures stand at -$13000.0 (Q1 2026), -$614000.0 (Q4 2025), and $63000.0 (Q3 2025).